/compare — side-by-sideLOADING

compare stocks // side-by-side, from filings

Compare any stocks, on the real numbers

Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.

Metric	GRIGRI Bio, Inc.
Last close	$1.46close 2026-11-02
Change %	-4.58%close 2026-11-02
Market cap	$3Mclose 2026-11-02
P/E	loss, no P/E
Revenue	$0 ⊙ EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2021-12-31 Filing10-K · 0001824293-22-000004 · filed 2022-02-14 Open the filing on EDGAR →Open the XBRL payload → CiteGRI Bio, Inc. (GRI), us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax: 0 USD, fiscal year ended 2021-12-31. Form 10-K, accession 0001824293-22-000004, filed 2022-02-14. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001824293/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json

Share this comparisonSend GRI side-by-side — free, straight from the filings.

Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.